Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House approves PBM transparency bill after sponsor says it will lift 'gag' clauses and clarify DIR fees
Summary
The House adopted Fourth Substitute SB 208 to prohibit PBM contract "gag" provisions that prevent pharmacists from telling customers about cheaper options and to require reporting of DIR fees; sponsor said the substitute removes much opposition and the House passed it 71–0.
The Utah House adopted the fourth substitute of Senate Bill 208 on March 7, a measure the sponsor described as aimed at increasing transparency in pharmacy benefit manager (PBM) contracts and giving pharmacists more ability to help consumers.
Representative Ray, sponsor of the substituted bill, told colleagues the measure targets contractual provisions that prevent pharmacists from disclosing cheaper ways to buy a drug. "They can't contract and tell the pharmacist that they can't tell you that instead of paying your $25 co-pay, that you might be able to just buy this for $5 if you paid directly for this," Ray…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
